Thomas C. Pearson

Emory Healthcare — United States

Immunology and Microbiology · Life Sciences

77h-index20.9kcitations351works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

T-cell and B-cell Immunology(71), Myeloproliferative Neoplasms: Diagnosis and Treatment(64), Immune Cell Function and Interaction(56), Hemoglobinopathies and Related Disorders(55), Renal Transplantation Outcomes and Treatments(49)

Publications351 total

Transcriptomic Insights into HIV Rejection Profiles in Renal Transplant Recipients
American Journal of Transplantation·2025
Mechanistic Insights Underlying Persistent Beneficial Impact on Kidney Function of CCR5 Blockade Following Treatment Discontinuation
American Journal of Transplantation·2025
Impact of Maraviroc on Circulating and Tissue Markers of Kidney Transplant Recipients with HIV
American Journal of Transplantation·2025
225.4: CCR5 Blockade: A novel, safe, and efficacious addition to the immunosuppressive armamentarium following kidney transplantation.
Transplantation·2024
Fostering Professional Research Skills in the Undergraduate Accounting Curriculum
2023· 3 cited
Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor–free, Belatacept Plus Everolimus–based Immunosuppression
Transplantation Direct·2023· 6 citedOpen Access
Tax-compliant transfer pricing of intra-group services: The soft drink case
Journal of Accounting Education·2022· 4 cited
Temporal trends and current use of de novo belatacept in kidney transplant recipients in the United States
Clinical Transplantation·2021· 17 cited
National Landscape of Human Immunodeficiency Virus–Positive Deceased Organ Donors in the United States
Clinical Infectious Diseases·2021· 21 citedOpen Access
Family vouchers—Unique innovation in need of continuous quality assurance
American Journal of Transplantation·2020· 2 citedOpen Access
CMV high-risk status and posttransplant outcomes in kidney transplant recipients treated with belatacept
American Journal of Transplantation·2020· 75 citedOpen Access
Belatacept and CD28 Costimulation Blockade: Preventing and Reducing Alloantibodies over the Long Term
Current Transplantation Reports·2019· 17 citedOpen Access
The impact of belatacept on third-party HLA alloantibodies in highly sensitized kidney transplant recipients
American Journal of Transplantation·2019· 24 citedOpen Access
Spinal dural arteriovenous fistulae: a single centre experience
European Society of Radiology·2019Open Access
Rheology of Polycythemias T. C. Pearson
2019
The Effects of the Extant Clauses Limiting Auditor Liability on Audit Fees and Overall Reporting Quality
Journal of Empirical Legal Studies·2019· 6 cited
Kinetics of antibody response to influenza vaccination in renal transplant recipients
Transplant Immunology·2019· 28 citedOpen Access
Tax governance: the balance between tax regulatory requirements and societal expectations
International Journal of Corporate Governance·2019Open Access
Tax governance: the balance between tax regulatory requirements and societal expectations
International Journal of Corporate Governance·2019· 1 citedOpen Access
Transplant Center Patient Navigator and Access to Transplantation among High-Risk Population
Clinical Journal of the American Society of Nephrology·2018· 54 citedOpen Access
page 1 of 18Next →

Frequent Co-authors

Christian P. Larsen(35), Andrew Adams(11), Peter S. Linsley(9), Eric T. Elwood(8), Megan M. Durham(8), Rafi Ahmed(7), Rose Hendrix(6), Nozomu Shirasugi(6), Shannon Cowan(6), Diane Z. Alexander(5), Shannon C. Ritchie(5), Alejandro Aruffo(5), Kevin J. Winn(5), Elizabeth Strobert(5), Diane Hollenbaugh(4), Matthew A. Williams(4), R P Lowry(4), Jongwon Ha(4), Jason K. Whitmire(4), Phyllis A. Rees(4)